gebhart/patrepeval huggingface dataset:
A high Brillouin amplification using liquid fluorocarbon (2010)

Although the gain coefficient of the Stimulated Brillouin Scattering (SBS) of the fluorocarbon liquid C<sub>8</sub>F<sub>18</sub> is substantially lower than for other nonlinear media, it is an attractive medium since its highly purified version has a high optical breakdown threshold, and it is stable and very safe to operate. We have utilized it as a phase conjugate mirror (PCM) and the PCM reflectivity better than 90% has been achieved at optimized focusing conditions of an incoming beam. The output energy of the phase conjugated pulse linearly followed the input pulse energy after reaching the threshold level at about 3.3 mJ. The slope efficiency was estimated about 95% without taking into account components' losses. Brillouin amplification through SBS has been realized in highly purified fluorocarbon liquid C<sub>8</sub>F<sub>18</sub>. This report discusses the design and results of performed experimental studies of the SBS in C<sub>8</sub>F<sub>18</sub> demonstrating the amplification of a week signal beam (37 nJ) reaching up to 10<sup>5</sup> or 50 dB.
Enhanced spontaneous backscattering in Brillouin dynamic gratings (2013)

Spontaneous Brillouin backscattering, which accompanies the operation of Brillouin dynamic gratings (BDGs) setups, is investigated both theoretically and experimentally. It is shown that this noisy emission, which cannot be separated from the signal of interest, contains not only the probe spontaneous Brillouin backscattering but also a significant contribution from the spontaneous/stimulated acoustic field, originating from the high-frequency writing pump. In the absence of the low-frequency writing pump and for a strong enough high-frequency writing pump, the observed Stokes noise can exhibit an average backscattered power much higher than that from the probe alone.
Exploiting the Shape of CAN Data for In-Vehicle Intrusion Detection (2018)

Modern vehicles rely on scores of electronic control units (ECUs) broadcasting messages over a few controller area networks (CANs). Bereft of security features, in-vehicle CANs are exposed to cyber manipulation and multiple researches have proved viable, life-threatening cyber attacks. Complicating the issue, CAN messages lack a common mapping of functions to commands, so packets are observable but not easily decipherable. We present a transformational approach to CAN IDS that exploits the geometric properties of CAN data to inform two novel detectors--one based on distance from a learned, lower dimensional manifold and the other on discontinuities of the manifold over time. Proof-of-concept tests are presented by implementing a potential attack approach on a driving vehicle. The initial results suggest that (1) the first detector requires additional refinement but does hold promise; (2) the second detector gives a clear, strong indicator of the attack; and (3) the algorithms keep pace with high-speed CAN messages. As our approach is data-driven it provides a vehicle-agnostic IDS that eliminates the need to reverse engineer CAN messages and can be ported to an after-market plugin.
Therapeutic patient education for stroke survivors: Non-pharmacological management. A literature review (2012)

TPE programs for stroke survivors could be improved by standardizing and assessing programs that focus on a specific problem caused by the various possible after-effects of strokes. In order to promote education for stroke survivors, specific training for health care professionals and appropriate funding are necessary.
Partial order based approach to synthesis of speed-independent circuits (2002)

This paper introduces a novel technique for synthesis of speed-independent circuits from their Signal Transition Graph specifications. The new method uses partial order in the form of the STG-unfolding segment to derive the logic implementation using approximation techniques. It is based on a new nation of slice which localises the behaviour of a particular signal instance in a structural fragment of the segment. The experimental results show the power of the approximation approach in comparison with the existing methods.
Different affinity of galectins for human serum glycoproteins: Galectin-3 binds many protease inhibitors and acute phase proteins (2008)

Here we report the first survey of galectins binding to glycoproteins of human serum. Serum was subjected to affinity chromatography using immobilized galectins, and the bound glycoproteins were analyzed by electrophoresis, Western blotting, and mass spectrometry. Galectins-3, -8, and -9 bound a much broader range of ligands in serum than previously known, galectin-1 bound less, and galectins-2, -4, and -7 bound only traces or no serum ligands. Galectin-3 bound most major glycoproteins, including alpha-2-macroglobulin and acute phase proteins such as haptoglobin. It bound only a selected minor fraction of transferrin, and bound none or little of IgG. Galectins-8 and -9 bound a similar range of glycoproteins as galectin-3, but in lower amounts, and galectin-8 had a relative preference for IgA. Galectin-1 bound mainly a fraction of alpha-2-macroglobulin and only traces of other glycoproteins. The binding of galectin-3 to serum glycoproteins requires affinity for LacNAc, since a mutant (R186S), which has lost this affinity, did not bind any serum glycoproteins. The average affinity of galectin-3 for serum glycoproteins was estimated to correspond to K(d) approximately 1-5 muM by modeling of the affinity chromatography and a fluorescence anisotropy assay. Since galectins are expressed on endothelial cells and other cells exposed to serum components, this report gives new insight into function of galectins and the role of their different fine specificity giving differential binding to the serum glycoproteins.
Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates (2007)

To determine the effect of feeding formula containing long-chain PUFA (LCP) on immune function, healthy term infants were randomised at age 2 weeks to either a standard term formula (Formula; n 14) or the same formula supplemented with the LCP 20 : 4n-6 and 22 : 6n-3 (Formula+LCP; n 16). Peripheral blood was collected at 2 and 6 weeks to measure immune cell response (the rate of [3H]thymidine uptake and cytokine production after stimulation with phytohaemagglutinin (PHA)). Compared with cells from infants receiving only human milk (HM), the rate of [3H]thymidine uptake in response to PHA, but not IL-2 production, was lower for Formula+LCP infants (P < 0.05). Compared with HM-fed infants, Formula-fed infants (but not Formula+LCP infants) produced more TNF-alpha (unstimulated) and had a fewer CD3+CD44+ cells before stimulation and fewer CD11c+ cells post-stimulation (P < 0.05). However, compared with Formula-fed infants, the Formula+LCP infants had an immune cell distribution (higher percentage CD3+CD44+ and CD4+CD28+ cells) and cytokine profile (lower production of TNF-alpha post-stimulation) that did not differ from HM infants. Additionally, it was found that feeding infants formula during the first 10 d of life influenced immune function. These infants had a higher percentage of CD3+, CD4+CD28+, and lower percentage of CD14+ cells and produced more TNF-alpha and interferon-gamma after PHA stimulation than HM-fed infants (P < 0.05). These results demonstrate that early diet influences both the presence of specific cell types and function of infant blood immune cells. Since many diseases have a strong immunological component, these immune changes may be of physiological importance to the developing infant.
ChemInform Abstract: THE PENEMS, A NEW CLASS OF β‐LACTAM ANTIBIOTICS. 2. TOTAL SYNTHESIS OF RACEMIC 6‐UNSUBSTITUTED REPRESENTATIVES (1980)

Abstract Die durc (I) mit z.B. den Thiolcarbonsäuren (II) dargestellten Acylmercaptoazetidinone (III) werden mit einem Halbaoetal des Glyoxylsäure‐p‐nitrobenzylesters zu Gemischen der diastereomeren Hydroxyverbindungen (IV) umgesetzt.
Synthesis, Structure, and Physical Properties of a Novel Quaternary Niobium Telluride, Nb2FeCu0.35Te4 (1994)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTSynthesis, Structure, and Physical Properties of a Novel Quaternary Niobium Telluride, Nb2FeCu0.35Te4Jing Li, Frank McCulley, Mark J. Dioszeghy, S. C. Chen, K. V. Ramanujachary, and M. GreenblattCite this: Inorg. Chem. 1994, 33, 10, 2109–2114Publication Date (Print):May 1, 1994Publication History Published online1 May 2002Published inissue 1 May 1994https://pubs.acs.org/doi/10.1021/ic00088a010https://doi.org/10.1021/ic00088a010research-articleACS PublicationsRequest reuse permissionsArticle Views142Altmetric-Citations2LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information Get e-Alerts
Different Proteolipid Protein Mutants Exhibit Unique Metabolic Defects (2009)

PMD (Pelizaeus-Merzbacher disease), a CNS (central nervous system) disease characterized by shortened lifespan and severe neural dysfunction, is caused by mutations of the PLP1 (X-linked myelin proteolipid protein) gene. The majority of human PLP1 mutations are caused by duplications; almost all others are caused by missense mutations. The cellular events leading to the phenotype are unknown. The same mutations in non-humans make them ideal models to study the mechanisms that cause neurological sequelae. In the present study we show that mice with Plp1 duplications (Plp1tg) have major mitochondrial deficits with a 50% reduction in ATP, a drastically reduced mitochondrial membrane potential and increased numbers of mitochondria. In contrast, the jp (jimpy) mouse with a Plp1 missense mutation exhibits normal mitochondrial function. We show that PLP in the Plp1tg mice and in Plp1-transfected cells is targeted to mitochondria. PLP has motifs permissive for insertion into mitochondria and deletions near its N-terminus prevent its co-localization to mitochondria. These novel data show that Plp1 missense mutations and duplications of the native Plp1 gene initiate uniquely different cellular responses.
High temperature fibre optic based sensor interrogated by a fast tuneable ring laser (2008)

A High temperature probe, based on a miniature fibre optic Fabry-Perot, operational temperature 700degC set by the maximum temperature of the gold plated optical fibre transceiver link used is presented. The probe is interrogated by a tuneable laser at 1300 nm, line width ~90 nm, with a second stage booster amplifier giving a maximum quasi-static output power of ~27 mW. Scanning rates of 1 kHz and 20 kHz for linear and sinusoidal scans respectively.
Hydrolytic potential of five fungal supernatants to enhance a commercial enzyme cocktail (2017)

Supplementing commercial cocktails with enzymes from carefully selected fungi may result in significantly more efficient saccharification of lignocellulosic materials. Furthermore, such an approach could lead to the identification of novel enzyme activities crucial for saccharification.
Research Article Caffeine intake induces an alteration in human neutrophil A 2A adenosine receptors (2005)

Caffeine is the most widely used drug in the world and acts mainly through antagonism of the effects mediated by the adenosine receptor subtypes A1, A2A, A2B and A3. We determined whether repeated caffeine admin- istration at different doses and for different periods of time (400 or 600 mg/day for 1 week and 400 mg/day for 2 weeks) alters human neutrophil A2A adenosine receptor density and function. Saturation binding assays showed an increase in affinity (K D) and density (Bmax) of A2A adenosine receptors after caffeine intake. These changes were accompanied by increases in cAMP accumula- tion and decreases in superoxide anion production after stimulation of the A2A receptor subtype using the agonist 5'-N-ethylcarboxamidoadenosine (NECA). Binding and functional changes of A2A receptors returned to baseline after 48 h of caffeine withdrawal. The findings are con - sistent with a potential anti-inflammatory effect of caf - feine mediated by neutrophil A2A receptors.
ChemInform Abstract: Hydrophosphonylation of Activated Alkenes and Alkynes via Fluoride Ion Activation in Ionic Liquid Medium. (2009)

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Gain-bandwidth product of a VCSEL amplifier (2002)

An analytical expression is presented for the gain-bandwidth product of a VCSEL amplifier, which predicts gain-bandwidth products of up to 80 GHz. Gain measurements have been carried out, and bandwidth measurements will be carried out to test the validity of the theoretical predictions.
Supplementary Figure 2 from Therapeutic Mechanism and Efficacy of the Antibody–Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9 (2023)

&lt;p&gt;PDF file - 65K, Targeted tubulin disruption by BAY 79-4620.&lt;/p&gt;
Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry tools (2002)

Cellular behavior is complex. Successfully understanding systems at ever-increasing complexity is fundamental to advances in modern science and unraveling the functional details of cellular behavior is no exception. We present a collection of prospectives to provide a glimpse of the techniques that will aid in collecting, managing and utilizing information on complex cellular processes via molecular imaging tools. These include: 1) visualizing intracellular protein activity with fluorescent markers, 2) high throughput (and automated) imaging of multilabeled cells in statistically significant numbers, and 3) machine intelligence to analyze subcellular image localization and pattern. Although not addressed here, the importance of combining cell-image-based information with detailed molecular structure and ligand-receptor binding models cannot be overlooked. Advanced molecular imaging techniques have the potential to impact cellular diagnostics for cancer screening, clinical correlations of tissue molecular patterns for cancer biology, and cellular molecular interactions for accelerating drug discovery. The goal of finally understanding all cellular components and behaviors will be achieved by advances in both instrumentation engineering (software and hardware) and molecular biochemistry. J. Cell. Biochem. Suppl. 39: 194–210, 2002. © 2002 Wiley-Liss, Inc.
Phase II trial of induction mFOLFOX6 plus bevacizumab followed by neoadjuvant S-1-based chemoradiation for MRI-defined poor-risk rectal cancer. (2016)

700 Background: Induction chemotherapy has been explored as a novel treatment option to improve oncological outcomes in poor-risk locally advanced rectal cancer (LARC). Although previous studies have suggested high pCR rate with a favorable toxicity profile in S-1-based neoadjuvant chemoradiation, no study has evaluated induction chemotherapy added with this regimen. The present study is designed to evaluate the safety and efficacy of induction chemotherapy with bevacizumab followed by neoadjuvant S-1 based chemoradiation in MRI-defined poor-risk LARC. Methods: This was a single-center phase II trial at a high-volume cancer center. Eligible patients had low rectal adenocarcinoma with MRI-defined poor-risk features. Patients received 12-week (6 course) mFOLFOX plus bevacizumab (5 mg/kg every 2 weeks) followed by concomitant oral S-1 (80mg/m2/day on days 1-5, 8-12, 22-27, and 29-33) plus radiotherapy (50.4Gy). Surgery was scheduled for 6-10 weeks after chemoradiation. Pathological complete response (pCR) was the primary endpoint. Results: A total of 43 eligible patients were enrolled. Forty-two patients (98%) completed induction chemotherapy. Forty-two patients (98%) completed planned radiation dose. One patient with cCR after completion of preoperative treatment declined surgery, but all the other 42 patients (98%) underwent R0 resection thorough a laparoscopic approach. A pCR was achieved in 16 patients (37%; 95% confidence interval 24.4%-52.1%). CTCAE grade 3 adverse events (AEs) occurred in 4 patients (9.3%) during induction chemotherapy and 5 patients (12%) during chemoradiation. There were no grade 4 AEs. Clavien-Dindo Classification grade III-IV surgical complications occurred in 6 patients (14%), including 1 grade IVa delirium, 1 grade IIIb anastomotic leakage, 1 grade IIIb bleeding, 2 grade IIIa pelvic abscess and 1 grade IIIa urethral fistula. There was no mortality. Conclusions: Induction FOLFOX plus bevacizumab followed by S-1-based chemoradiation achieved a high pCR rate with favorable toxicity and tolerable surgical complications in poor-risk LARC. Phase III trial is needed for further evaluation. Clinical trial information: UMIN000011457.
Area‐selective atomic layer deposition on HOPG enabled by writable electron beam functionalization (2022)

Abstract Area‐selective atomic layer deposition (AS‐ALD) techniques are an emerging class of bottom‐up nanofabrication techniques that selectively deposit patterned ALD films without the need for conventional top‐down lithography. To achieve this patterning, most reported AS‐ALD techniques use a chemical inhibitor layer to proactively block ALD surface reactions in selected areas. Herein, an AS‐ALD process is demonstrated that uses a focused electron beam (e‐beam) to dissociate ambient water vapor and “write” highly resolved hydroxylated patterns on the surface of highly oriented pyrolytic graphite (HOPG). The patterned hydroxylated regions then support subsequent ALD deposition. The e‐beam functionalization technique facilitates precise pattern placement through control of beam position, dwell time, and current. Spatial resolution of the technique exceeded 42 nm, with a surface selectivity of between 69.9% and 99.7%, depending on selection of background nucleation regions. This work provides a fabrication route for AS‐ALD on graphitic substrates suitable for fabrication of graphene‐based nanoelectronics.
Abstract A261: <i>In vitro</i> characterization of AMG 900, an orally active small molecule inhibitor of aurora kinases in phase 1 clinical trials (2009)

Abstract Background: The aurora family of serine-threonine kinases (Aurora-A, -B, -C) regulate cell-cycle progression in mammalian cells. Aurora kinases A and B are essential for proper chromosome congression, segregation, and cytokinesis during mitosis, whereas aurora kinase C function appears restricted to male meiosis. Aurora kinase B is responsible for the direct phosphorylation of histone H3 on serine-10 (p-histone H3). Aurora kinase A and B expression is elevated in a variety of human cancers and is associated with advanced clinical staging and poor prognosis. The emergence of aurora kinases as key mitotic regulators and their potential role in tumorigenesis has focused substantial interest in developing selective small molecule inhibitors for the treatment of human cancers. Objective: The aim of this study was to characterize the in vitro effects of AMG 900 in tumor cell lines, including cell lines resistant to paclitaxel and three well-characterized aurora kinase inhibitors. Results: AMG 900 is a novel ATP competitive small molecule inhibitor that is highly potent and selective for aurora kinases A, B, and C. In cells, AMG 900 inhibits autophosphorylation of aurora kinases A and B as well as the phosphorylation of histone H3. The predominant cellular response of tumor cells to AMG 900 treatment is aborted cell division without a mitotic arrest, which leads to endoreduplication and cell death. The effect of AMG 900 was tested in a panel of 26 tumor cell lines to evaluate its potential to inhibit cell proliferation across multiple tumor types. AMG 900 inhibited the proliferation of tumor cell lines at low nanomolar concentrations (EC50 values 1–6 nM). Importantly, AMG 900 was equally potent against multidrugresistant (MDR) cell lines expressing ATP-binding cassette transporters (P-gp and BCRP1), whereas paclitaxel and three aurora kinase inhibitors (AZD1152, MK-0457, and PHA-739358) showed a loss of potency in these MDR-positive cell lines compared with matched parental cell lines. To further investigate potential mechanisms of resistance, an HCT116 cell line was adapted to grow in the presence of AZD1152, a selective inhibitor of aurora kinase B. The resulting AZD1152-resistant HCT116 subline harbors a mutation in one allele of the aurora kinase B gene (W221L substitution) and was negative for P-gp and BCRP1 expression. AMG 900 induced an accumulation of cells with ≥4N DNA content (EC50 value 5 nM) and inhibited colony formation in this AZD1152-resistant HCT116 subline. Conclusion: To our knowledge, AMG 900 is the first described inhibitor of aurora kinases A, B, and C that has uniform in vitro potency in MDR-positive tumor cell lines. AMG 900 is currently undergoing phase 1 clinical evaluation in patients with advanced solid tumors. Citation Information: Mol Cancer Ther 2009;8(12 Suppl):A261.
Signal recognition particle receptor is important for cell growth and protein secretion in Saccharomyces cerevisiae. (1992)

In mammalian cells, the signal recognition particle (SRP) receptor is required for the targeting of nascent secretory proteins to the endoplasmic reticulum (ER) membrane. We have identified the Saccharomyces cerevisiae homologue of the alpha-subunit of the SRP receptor (SR alpha) and characterized its function in vivo. S. cerevisiae SR alpha is a 69-kDa peripheral membrane protein that is 32% identical (54% chemically similar) to its mammalian homologue and, like mammalian SR alpha, is predicted to contain a GTP binding domain. Yeast cells that contain the SR alpha gene (SRP101) under control of the GAL1 promoter show impaired translocation of soluble and membrane proteins across the ER membrane after depletion of SR alpha. The degree of the translocation defect varies for different proteins. The defects are similar to those observed in SRP deficient cells. Disruption of the SRP101 gene results in an approximately sixfold reduction in the growth rate of the cells. Disruption of the gene encoding SRP RNA (SCR1) or both SCR1 and SRP101 resulted in an indistinguishable growth phenotype, indicating that SRP receptor and SRP function in the same pathway. Taken together, these results suggest that the components and the mechanism of the SRP-dependent protein targeting pathway are evolutionarily conserved yet not essential for cell growth. Surprisingly, cells that are grown for a prolonged time in the absence of SRP or SRP receptor no longer show pronounced protein translocation defects. This adaptation is a physiological process and is not due to the accumulation of a suppressor mutation. The degree of this adaptation is strain dependent.